External reports (aggregated public sources), Value Investors Club

Value Investors Club

Value Investors Club (.com) is an exclusive online investment club where top investors share their best ideas. Content available at the above link/PDF preview is an external article authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

External reports (aggregated public sources)

Equity Bottom-Up

<ul><li>TG Therapeutics focuses on developing treatments for B-cell mediated diseases, including their flagship product Briumvi for Multiple Sclerosis</li><li>The company has a pipeline of other products such as Umbralisib, TG-1701, and TG-1801 in development</li><li>Briumvi is an anti-CD20 monoclonal antibody targeted at specific types of MS, showcasing the company's commitment to addressing unmet medical needs in the field</li></ul><p><em>This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.</em></p>

TG Therapeutics focuses on developing treatments for B-cell mediated diseases, including their flagship product Briumvi for Multiple SclerosisThe company has a pipeline of other products such as Umbralisib, TG-1701, and TG-1801 in developmentBriumvi is an anti-CD20 monoclonal antibody targeted at specific types of MS, showcasing the company's commitment to addressing unmet medical needs in the fieldThis content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Tg Therapeutics Inc (TGTX) - Thursday, Apr 11, 2024